News Tagged ‘glaxosmithkline plc’

Two U.S. healthcare providers drop Glaxo’s Avandia

Two U.S. pharmacy benefit managers said on Thursday they had dropped Plc’s (GSK.L: Quote, Profile, Research) drug Avandia from their national formularies due to safety concerns.

Read the rest of this entry »

FDA study said to show Avandia risk

The government’s own preliminary evaluation of the pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on the market eight years ago, a leading member of Congress said Thursday.

Read the rest of this entry »